SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-13-004578
Filing Date
2013-11-12
Accepted
2013-11-12 10:57:40
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_111213.htm 10-Q 389264
2 EXHIBIT 10.1 exh_101.htm EX-10.1 13862
3 EXHIBIT 31.1 exh_311.htm EX-31.1 11524
4 EXHIBIT 31.2 exh_312.htm EX-31.2 11797
5 EXHIBIT 32 exh_32.htm EX-32 6815
  Complete submission text file 0001171843-13-004578.txt   1845023

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT caps-20130930.xml EX-101.INS 161790
7 XBRL TAXONOMY EXTENSION SCHEMA caps-20130930.xsd EX-101.SCH 20825
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE caps-20130930_cal.xml EX-101.CAL 23362
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE caps-20130930_def.xml EX-101.DEF 90645
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE caps-20130930_lab.xml EX-101.LAB 135223
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE caps-20130930_pre.xml EX-101.PRE 108955
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33560 | Film No.: 131208378
SIC: 2834 Pharmaceutical Preparations